GEHC
GE HealthCare Technologies Inc.
Price Chart
Latest Quote
$63.07
-2.63 (-4.00%)
Current Price
| Previous Close | $65.70 |
| Open | $65.63 |
| Day High | $66.28 |
| Day Low | $62.64 |
| Volume | 6,384,635 |
Stock Information
| Quarterly Dividend / Yield | $0.14 / 0.21% |
| Shares Outstanding | 454.89M |
| Quarterly Dividend Yield | 0.21% |
| Quarterly Dividend | $0.14 |
| Total Debt | $10.58B |
| Cash Equivalents | $2.26B |
| Revenue | $20.98B |
| Net Income | $1.91B |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $28.69B |
| P/E Ratio | 15.77 |
| EPS (TTM) | $4.00 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $37.24B |
| Sales | $20.98B |
| Income | $1.91B |
| Book/sh | $23.45 |
| Cash/sh | $4.97 |
| Employees | 54K |
Financial Ratios
| Quick Ratio | 0.81 |
| Current Ratio | 1.22 |
| Debt/Eq | 97.06 |
| EPS Growth TTM | -31.00% |
Returns & Margins
| ROA | 5.17% |
| ROE | 19.46% |
| Gross Margin | 39.14% |
| Operating Margin | 11.09% |
| Profit Margin | 9.10% |
Ownership
| Insider Ownership | 0.35% |
| Institutional Ownership | 94.80% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 11.76 |
| PEG | 1.74 |
| P/S | 1.37 |
| P/B | 2.69 |
Analyst Data
| Recommendation | buy |
| Target Price | $79.44 |
Technical Indicators
| SMA20 | $64.19 |
| SMA50 | $63.55 |
| SMA200 | $73.56 |
| RSI | 41.17 |
| ATR | 2.1172 |
| Shares Float | 453.44M |
| Short Float | 3.58% |
| Short Ratio | 2.85 |
| Volatility | 0.84 |
| Rel Volume | 1.17 |
Performance History
| Week | -2.52% |
| Month | -0.25% |
| Quarter | -13.84% |
| 6 Months | -26.02% |
| YTD | -23.78% |
| Year | -16.26% |
| 3 Years | -22.41% |
| 10 Years | +5.68% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-07-17 | $63.07 | 6,384,635 |
| 2026-07-16 | $65.70 | 6,112,500 |
| 2026-07-15 | $63.20 | 6,772,900 |
| 2026-07-14 | $61.66 | 12,141,800 |
| 2026-07-13 | $65.31 | 4,025,200 |
| 2026-07-10 | $64.70 | 2,559,700 |
| 2026-07-09 | $64.70 | 3,105,500 |
| 2026-07-08 | $64.68 | 4,039,200 |
| 2026-07-07 | $64.89 | 3,624,200 |
| 2026-07-06 | $64.84 | 4,932,800 |
| 2026-07-02 | $65.57 | 4,513,700 |
| 2026-07-01 | $64.86 | 3,717,900 |
| 2026-06-30 | $64.01 | 6,595,200 |
| 2026-06-29 | $65.05 | 4,010,800 |
| 2026-06-26 | $65.76 | 5,191,200 |
| 2026-06-25 | $64.94 | 4,483,600 |
| 2026-06-24 | $64.88 | 5,433,400 |
| 2026-06-23 | $63.72 | 7,762,700 |
| 2026-06-22 | $60.64 | 5,822,900 |
| 2026-06-18 | $61.59 | 8,337,100 |
About GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women's health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products. The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. The company has a strategic collaboration with DeepHealth. GE HealthCare Technologies Inc. was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
đ° Latest News
GEHC Stock Up on $500M Strategic Care Alliance With Catholic Health
Zacks âĸ 2026-07-17T14:26:00Z
GE HealthCare (GEHC) Lands $500 Million Catholic Health Deal For Imaging And AI
Simply Wall St. âĸ 2026-07-16T11:15:21Z
GE HealthCare Technologies (GEHC) Following Mayo Clinic Trial Tie Up Faces A Fresh Valuation Test
Simply Wall St. âĸ 2026-07-16T05:16:17Z
Can GE HealthCare (GEHC) Turn Theranostic Partnerships Into a Durable Advanced Diagnostics Edge?
Simply Wall St. âĸ 2026-07-15T15:12:43Z
Do Options Traders Know Something About GE HealthCare Stock We Don't?
Zacks âĸ 2026-07-14T14:49:00Z
GE HealthCare & Mayo Clinic Unite to Advance Cancer Theranostics
Zacks âĸ 2026-07-09T17:31:00Z
Here Are Thursdayâs Best Wall Street Analyst Research Calls: Align Technology, American Tower, Caesars Entertainment, Cohu, Five Below, Intuitive Surgical, Salesforce, Toast, and More
24/7 Wall St. âĸ 2026-07-09T11:52:34Z
GE HealthCare (GEHC) Introduces AI-Driven Upgrade Pathways to Modernize Legacy Imaging Suites
Insider Monkey âĸ 2026-07-06T18:24:53Z
Earnings Preview: What To Expect From GE HealthCare Technologiesâ Report
Barchart âĸ 2026-07-03T11:15:56Z
3 Reasons GEHC is Risky and 1 Stock to Buy Instead
StockStory âĸ 2026-07-01T14:09:00Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $12,378,000,000 | $11,467,000,000 | $11,630,000,000 | $11,162,000,000 |
| Cost Of Revenue | $12,378,000,000 | $11,467,000,000 | $11,630,000,000 | $11,162,000,000 |
| Total Revenue | $20,625,000,000 | $19,672,000,000 | $19,552,000,000 | $18,341,000,000 |
| Operating Revenue | $20,625,000,000 | $19,672,000,000 | $19,552,000,000 | $18,341,000,000 |
| Expenses | ||||
| Interest Expense | $440,000,000 | $505,000,000 | $542,000,000 | $86,000,000 |
| Total Expenses | $17,863,000,000 | $17,047,000,000 | $17,117,000,000 | $15,819,000,000 |
| Other Income Expense | $404,000,000 | $462,000,000 | $442,000,000 | $76,000,000 |
| Other Non Operating Income Expenses | $304,000,000 | $454,000,000 | $431,000,000 | $63,000,000 |
| Net Non Operating Interest Income Expense | $-399,000,000 | $-505,000,000 | $-516,000,000 | $-86,000,000 |
| Interest Expense Non Operating | $440,000,000 | $505,000,000 | $542,000,000 | $86,000,000 |
| Operating Expense | $5,485,000,000 | $5,580,000,000 | $5,487,000,000 | $4,657,000,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $2,084,000,000 | $1,993,000,000 | $1,572,000,000 | $1,898,000,000 |
| Net Interest Income | $-399,000,000 | $-505,000,000 | $-516,000,000 | $-86,000,000 |
| Interest Income | $41,000,000 | - | $26,000,000 | - |
| Normalized Income | $2,008,516,618 | $1,993,000,000 | $1,572,000,000 | $1,898,000,000 |
| Net Income From Continuing And Discontinued Operation | $2,084,000,000 | $1,993,000,000 | $1,568,000,000 | $1,916,000,000 |
| Total Operating Income As Reported | $2,763,000,000 | $2,625,000,000 | $2,435,000,000 | $2,522,000,000 |
| Net Income Common Stockholders | $2,084,000,000 | $1,993,000,000 | $1,385,000,000 | $1,916,000,000 |
| Net Income | $2,084,000,000 | $1,993,000,000 | $1,568,000,000 | $1,916,000,000 |
| Net Income Including Noncontrolling Interests | $2,154,000,000 | $2,050,000,000 | $1,614,000,000 | $1,967,000,000 |
| Net Income Discontinuous Operations | $0 | $0 | $-4,000,000 | $18,000,000 |
| Net Income Continuous Operations | $2,154,000,000 | $2,050,000,000 | $1,618,000,000 | $1,949,000,000 |
| Pretax Income | $2,768,000,000 | $2,581,000,000 | $2,361,000,000 | $2,512,000,000 |
| Earnings From Equity Interest | $3,000,000 | $8,000,000 | $11,000,000 | $13,000,000 |
| Interest Income Non Operating | $41,000,000 | - | $26,000,000 | - |
| Operating Income | $2,762,000,000 | $2,625,000,000 | $2,435,000,000 | $2,522,000,000 |
| Gross Profit | $8,247,000,000 | $8,205,000,000 | $7,922,000,000 | $7,179,000,000 |
| Per Share | ||||
| Diluted EPS | $4.55 | $4.34 | $3.03 | $4.63 |
| Basic EPS | $4.56 | $4.37 | $3.05 | $4.63 |
| Other | ||||
| Tax Effect Of Unusual Items | $21,516,618 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $3,689,000,000 | $3,666,000,000 | $3,513,000,000 | $3,231,000,000 |
| Total Unusual Items | $97,000,000 | - | - | - |
| Total Unusual Items Excluding Goodwill | $97,000,000 | - | - | - |
| Reconciled Depreciation | $578,000,000 | $580,000,000 | $610,000,000 | $633,000,000 |
| EBITDA (Bullshit earnings) | $3,786,000,000 | $3,666,000,000 | $3,513,000,000 | $3,231,000,000 |
| EBIT | $3,208,000,000 | $3,086,000,000 | $2,903,000,000 | $2,598,000,000 |
| Diluted Average Shares | $458,000,000 | $459,000,000 | $458,000,000 | $413,822,894 |
| Basic Average Shares | $456,000,000 | $456,000,000 | $455,000,000 | $413,822,894 |
| Diluted NI Availto Com Stockholders | $2,084,000,000 | $1,993,000,000 | $1,385,000,000 | $1,916,000,000 |
| Minority Interests | $-70,000,000 | $-57,000,000 | $-46,000,000 | $-51,000,000 |
| Tax Provision | $614,000,000 | $531,000,000 | $743,000,000 | $563,000,000 |
| Gain On Sale Of Security | $97,000,000 | - | - | - |
| Research And Development | $1,260,000,000 | $1,311,000,000 | $1,205,000,000 | $1,026,000,000 |
| Selling General And Administration | $4,225,000,000 | $4,269,000,000 | $4,282,000,000 | $3,631,000,000 |
| Preferred Stock Dividends | - | - | $183,000,000 | - |
Fetched: 2026-07-13
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-4,240,000,000 | $-5,768,000,000 | $-7,056,000,000 | $-4,976,000,000 |
| Total Assets | $36,906,000,000 | $33,089,000,000 | $32,454,000,000 | $27,539,000,000 |
| Total Non Current Assets | $24,406,000,000 | $23,189,000,000 | $23,044,000,000 | $19,221,000,000 |
| Other Non Current Assets | $233,000,000 | $281,000,000 | $338,000,000 | $172,000,000 |
| Non Current Deferred Assets | $4,691,000,000 | $4,558,000,000 | $4,474,000,000 | $1,550,000,000 |
| Non Current Deferred Taxes Assets | $4,491,000,000 | $4,474,000,000 | $4,474,000,000 | $1,550,000,000 |
| Non Current Accounts Receivable | $591,000,000 | $533,000,000 | $470,000,000 | $460,000,000 |
| Financial Assets | $88,000,000 | $22,000,000 | - | - |
| Goodwill And Other Intangible Assets | $14,619,000,000 | $14,214,000,000 | $14,189,000,000 | $14,333,000,000 |
| Other Intangible Assets | $1,130,000,000 | $1,078,000,000 | $1,253,000,000 | $1,520,000,000 |
| Current Assets | $12,501,000,000 | $9,901,000,000 | $9,410,000,000 | $8,318,000,000 |
| Other Current Assets | $81,000,000 | $15,000,000 | $8,000,000 | $94,000,000 |
| Hedging Assets Current | $169,000,000 | $123,000,000 | $84,000,000 | $63,000,000 |
| Current Deferred Assets | $428,000,000 | $385,000,000 | $400,000,000 | $405,000,000 |
| Restricted Cash | $20,000,000 | $16,000,000 | $10,000,000 | $5,000,000 |
| Prepaid Assets | $228,000,000 | $188,000,000 | $147,000,000 | $163,000,000 |
| Inventory | $2,234,000,000 | $1,939,000,000 | $1,960,000,000 | $2,155,000,000 |
| Receivables | $4,849,000,000 | $4,361,000,000 | $4,307,000,000 | $3,993,000,000 |
| Receivables Adjustments Allowances | $-103,000,000 | $-103,000,000 | $-98,000,000 | $-91,000,000 |
| Other Receivables | $920,000,000 | $812,000,000 | $815,000,000 | $781,000,000 |
| Taxes Receivable | $313,000,000 | $270,000,000 | $219,000,000 | $174,000,000 |
| Accounts Receivable | $3,719,000,000 | $3,382,000,000 | $3,339,000,000 | $3,112,000,000 |
| Cash Cash Equivalents And Short Term Investments | $4,492,000,000 | $2,874,000,000 | $2,494,000,000 | $1,440,000,000 |
| Cash And Cash Equivalents | $4,492,000,000 | $2,874,000,000 | $2,494,000,000 | $1,440,000,000 |
| Debt | ||||
| Net Debt | $5,511,000,000 | $6,077,000,000 | $6,948,000,000 | $6,809,000,000 |
| Total Debt | $10,463,000,000 | $9,376,000,000 | $9,863,000,000 | $8,635,000,000 |
| Long Term Debt And Capital Lease Obligation | $9,821,000,000 | $7,759,000,000 | $8,747,000,000 | $8,516,000,000 |
| Long Term Debt | $9,495,000,000 | $7,449,000,000 | $8,436,000,000 | $8,234,000,000 |
| Current Debt And Capital Lease Obligation | $642,000,000 | $1,617,000,000 | $1,116,000,000 | $119,000,000 |
| Current Debt | $508,000,000 | $1,502,000,000 | $1,006,000,000 | $15,000,000 |
| Other Current Borrowings | $508,000,000 | $1,502,000,000 | $1,006,000,000 | $15,000,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $26,307,000,000 | $24,437,000,000 | $25,144,000,000 | $17,947,000,000 |
| Total Non Current Liabilities Net Minority Interest | $17,202,000,000 | $14,884,000,000 | $16,163,000,000 | $10,756,000,000 |
| Other Non Current Liabilities | $203,000,000 | $208,000,000 | $252,000,000 | $321,000,000 |
| Derivative Product Liabilities | $160,000,000 | $64,000,000 | $136,000,000 | $119,000,000 |
| Tradeand Other Payables Non Current | $156,000,000 | $237,000,000 | $208,000,000 | - |
| Non Current Deferred Liabilities | $996,000,000 | $742,000,000 | $773,000,000 | $1,000,000,000 |
| Non Current Deferred Taxes Liabilities | $193,000,000 | $56,000,000 | $68,000,000 | $370,000,000 |
| Current Liabilities | $9,105,000,000 | $9,553,000,000 | $8,981,000,000 | $7,191,000,000 |
| Other Current Liabilities | $651,000,000 | $718,000,000 | $691,000,000 | $567,000,000 |
| Current Deferred Liabilities | $2,095,000,000 | $1,943,000,000 | $1,918,000,000 | $1,896,000,000 |
| Payables And Accrued Expenses | $3,871,000,000 | $3,569,000,000 | $3,525,000,000 | $3,529,000,000 |
| Interest Payable | $100,000,000 | $92,000,000 | $87,000,000 | $52,000,000 |
| Payables | $3,574,000,000 | $3,314,000,000 | $3,306,000,000 | $3,327,000,000 |
| Total Tax Payable | $324,000,000 | $279,000,000 | $260,000,000 | $237,000,000 |
| Accounts Payable | $3,250,000,000 | $3,035,000,000 | $2,947,000,000 | $2,944,000,000 |
| Equity | ||||
| Common Stock Equity | $10,379,000,000 | $8,446,000,000 | $7,133,000,000 | $9,357,000,000 |
| Total Equity Gross Minority Interest | $10,599,000,000 | $8,652,000,000 | $7,310,000,000 | $9,592,000,000 |
| Stockholders Equity | $10,379,000,000 | $8,446,000,000 | $7,133,000,000 | $9,357,000,000 |
| Other Equity Interest | $-1,000,000 | - | - | $11,235,000,000 |
| Gains Losses Not Affecting Retained Earnings | $-1,388,000,000 | $-1,379,000,000 | $-691,000,000 | $-1,878,000,000 |
| Other Equity Adjustments | $-1,388,000,000 | $-1,379,000,000 | $-691,000,000 | $-1,878,000,000 |
| Retained Earnings | $5,281,000,000 | $3,262,000,000 | $1,326,000,000 | $0 |
| Long Term Equity Investment | $351,000,000 | $373,000,000 | $357,000,000 | $322,000,000 |
| Preferred Securities Outside Stock Equity | - | - | - | - |
| Other | ||||
| Treasury Shares Number | $3,107,626 | $291,053 | $0 | - |
| Ordinary Shares Number | $455,736,583 | $456,955,918 | $455,342,290 | $454,000,000 |
| Share Issued | $458,844,209 | $457,246,971 | $455,342,290 | $454,000,000 |
| Tangible Book Value | $-4,240,000,000 | $-5,768,000,000 | $-7,056,000,000 | $-4,976,000,000 |
| Invested Capital | $20,382,000,000 | $17,397,000,000 | $16,575,000,000 | $17,606,000,000 |
| Working Capital | $3,396,000,000 | $348,000,000 | $429,000,000 | $1,127,000,000 |
| Capital Lease Obligations | $460,000,000 | $425,000,000 | $421,000,000 | $386,000,000 |
| Total Capitalization | $19,874,000,000 | $15,895,000,000 | $15,569,000,000 | $17,591,000,000 |
| Minority Interest | $220,000,000 | $206,000,000 | $177,000,000 | $235,000,000 |
| Treasury Stock | $225,000,000 | $25,000,000 | $0 | - |
| Additional Paid In Capital | $6,707,000,000 | $6,583,000,000 | $6,493,000,000 | $0 |
| Capital Stock | $5,000,000 | $5,000,000 | $5,000,000 | $11,235,000,000 |
| Common Stock | $5,000,000 | $5,000,000 | $5,000,000 | $11,235,000,000 |
| Employee Benefits | $5,453,000,000 | $5,583,000,000 | $5,782,000,000 | $549,000,000 |
| Non Current Deferred Revenue | $803,000,000 | $686,000,000 | $705,000,000 | $630,000,000 |
| Long Term Capital Lease Obligation | $326,000,000 | $310,000,000 | $311,000,000 | $282,000,000 |
| Long Term Provisions | $413,000,000 | $291,000,000 | $265,000,000 | $251,000,000 |
| Current Deferred Revenue | $2,095,000,000 | $1,943,000,000 | $1,918,000,000 | $1,896,000,000 |
| Current Capital Lease Obligation | $134,000,000 | $115,000,000 | $110,000,000 | $104,000,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $1,666,000,000 | $1,521,000,000 | $1,518,000,000 | $853,000,000 |
| Current Provisions | $180,000,000 | $185,000,000 | $213,000,000 | $227,000,000 |
| Current Accrued Expenses | $297,000,000 | $255,000,000 | $219,000,000 | $202,000,000 |
| Defined Pension Benefit | $742,000,000 | $657,000,000 | $716,000,000 | $70,000,000 |
| Investments And Advances | $351,000,000 | $373,000,000 | $357,000,000 | $322,000,000 |
| Goodwill | $13,489,000,000 | $13,136,000,000 | $12,936,000,000 | $12,813,000,000 |
| Net PPE | $3,091,000,000 | $2,551,000,000 | $2,500,000,000 | $2,314,000,000 |
| Accumulated Depreciation | $-3,049,000,000 | $-3,080,000,000 | $-3,064,000,000 | $-2,988,000,000 |
| Gross PPE | $6,140,000,000 | $5,631,000,000 | $5,564,000,000 | $5,302,000,000 |
| Construction In Progress | $574,000,000 | $553,000,000 | $565,000,000 | $489,000,000 |
| Other Properties | $410,000,000 | $364,000,000 | $356,000,000 | $313,000,000 |
| Machinery Furniture Equipment | $2,872,000,000 | $2,705,000,000 | $2,617,000,000 | $2,541,000,000 |
| Buildings And Improvements | $2,140,000,000 | $1,943,000,000 | $1,956,000,000 | $1,889,000,000 |
| Land And Improvements | $144,000,000 | $66,000,000 | $70,000,000 | $70,000,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $1,137,000,000 | $926,000,000 | $908,000,000 | $1,011,000,000 |
| Work In Process | $95,000,000 | $92,000,000 | $91,000,000 | $91,000,000 |
| Raw Materials | $1,002,000,000 | $921,000,000 | $961,000,000 | $1,053,000,000 |
| Dueto Related Parties Current | - | $20,000,000 | $99,000,000 | $146,000,000 |
| Duefrom Related Parties Current | - | $5,000,000 | $32,000,000 | $17,000,000 |
Fetched: 2026-07-13
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $1,505,000,000 | $1,550,000,000 | $1,714,000,000 | $1,803,000,000 |
| Operating Activities | ||||
| Operating Cash Flow | $1,987,000,000 | $1,951,000,000 | $2,101,000,000 | $2,113,000,000 |
| Cash From Discontinued Operating Activities | $0 | $-4,000,000 | $0 | $-21,000,000 |
| Cash Flow From Continuing Operating Activities | $1,987,000,000 | $1,955,000,000 | $2,101,000,000 | $2,134,000,000 |
| Operating Gains Losses | $-605,000,000 | $-689,000,000 | $-689,000,000 | $-9,000,000 |
| Investing Activities | ||||
| Capital Expenditure | $-482,000,000 | $-401,000,000 | $-387,000,000 | $-310,000,000 |
| Investing Cash Flow | $-1,047,000,000 | $-914,000,000 | $-558,000,000 | $-398,000,000 |
| Cash Flow From Continuing Investing Activities | $-1,047,000,000 | $-914,000,000 | $-558,000,000 | $-398,000,000 |
| Net Other Investing Changes | $-69,000,000 | $-160,000,000 | $23,000,000 | $-33,000,000 |
| Cash From Discontinued Investing Activities | - | - | - | $0 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-200,000,000 | $0 | $0 | - |
| Financing Cash Flow | $617,000,000 | $-573,000,000 | $-478,000,000 | $-822,000,000 |
| Cash Flow From Continuing Financing Activities | $617,000,000 | $-573,000,000 | $-478,000,000 | $-822,000,000 |
| Net Other Financing Charges | $-124,000,000 | $-128,000,000 | $-1,610,000,000 | $-9,026,000,000 |
| Cash Dividends Paid | $-64,000,000 | $-55,000,000 | $-41,000,000 | $0 |
| Common Stock Dividend Paid | $-64,000,000 | $-55,000,000 | $-41,000,000 | $0 |
| Net Common Stock Issuance | $-200,000,000 | $0 | $0 | - |
| Cash From Discontinued Financing Activities | - | - | - | $0 |
| Other | ||||
| Repayment Of Debt | $-1,767,000,000 | $-1,418,000,000 | $-855,000,000 | $-3,000,000 |
| Issuance Of Debt | $2,734,000,000 | $995,000,000 | $2,006,000,000 | $8,198,000,000 |
| Interest Paid Supplemental Data | $522,000,000 | $550,000,000 | $570,000,000 | $0 |
| End Cash Position | $4,515,000,000 | $2,893,000,000 | $2,506,000,000 | $1,451,000,000 |
| Beginning Cash Position | $2,893,000,000 | $2,506,000,000 | $1,451,000,000 | $561,000,000 |
| Effect Of Exchange Rate Changes | $66,000,000 | $-77,000,000 | $-10,000,000 | $-3,000,000 |
| Changes In Cash | $1,556,000,000 | $464,000,000 | $1,065,000,000 | $893,000,000 |
| Proceeds From Stock Option Exercised | $37,000,000 | $33,000,000 | $34,000,000 | $0 |
| Common Stock Payments | $-200,000,000 | $0 | $0 | - |
| Net Issuance Payments Of Debt | $968,000,000 | $-423,000,000 | $1,139,000,000 | $8,204,000,000 |
| Net Short Term Debt Issuance | $1,000,000 | $0 | $-12,000,000 | $9,000,000 |
| Net Long Term Debt Issuance | $967,000,000 | $-423,000,000 | $1,151,000,000 | $8,195,000,000 |
| Long Term Debt Payments | $-1,767,000,000 | $-1,418,000,000 | $-855,000,000 | $-3,000,000 |
| Long Term Debt Issuance | $2,734,000,000 | $995,000,000 | $2,006,000,000 | $8,198,000,000 |
| Net Investment Purchase And Sale | $-118,000,000 | $-40,000,000 | $-48,000,000 | $-59,000,000 |
| Purchase Of Investment | $-118,000,000 | $-40,000,000 | $-48,000,000 | $-59,000,000 |
| Net Business Purchase And Sale | $-378,000,000 | $-313,000,000 | $-147,000,000 | $0 |
| Purchase Of Business | $-378,000,000 | $-313,000,000 | $-147,000,000 | $0 |
| Net PPE Purchase And Sale | $-482,000,000 | $-401,000,000 | $-386,000,000 | $-306,000,000 |
| Sale Of PPE | $0 | $0 | $1,000,000 | $4,000,000 |
| Purchase Of PPE | $-482,000,000 | $-401,000,000 | $-387,000,000 | $-310,000,000 |
| Taxes Refund Paid | $-429,000,000 | $-491,000,000 | $-474,000,000 | $-851,000,000 |
| Change In Working Capital | $-153,000,000 | $-68,000,000 | $27,000,000 | $-293,000,000 |
| Change In Other Working Capital | $175,000,000 | $107,000,000 | $179,000,000 | $101,000,000 |
| Change In Payables And Accrued Expense | $90,000,000 | $60,000,000 | $-100,000,000 | $448,000,000 |
| Change In Payable | $90,000,000 | $60,000,000 | $-100,000,000 | $448,000,000 |
| Change In Account Payable | $90,000,000 | $60,000,000 | $-100,000,000 | $481,000,000 |
| Change In Inventory | $-142,000,000 | $-81,000,000 | $111,000,000 | $-402,000,000 |
| Change In Receivables | $-276,000,000 | $-154,000,000 | $-163,000,000 | $-440,000,000 |
| Changes In Account Receivables | $-216,000,000 | $-157,000,000 | $-173,000,000 | $-231,000,000 |
| Other Non Cash Items | $-302,000,000 | $-83,000,000 | $152,000,000 | $75,000,000 |
| Stock Based Compensation | $130,000,000 | $125,000,000 | $114,000,000 | $67,000,000 |
| Deferred Tax | $614,000,000 | $531,000,000 | $743,000,000 | $563,000,000 |
| Deferred Income Tax | $614,000,000 | $531,000,000 | $743,000,000 | $563,000,000 |
| Depreciation Amortization Depletion | $578,000,000 | $580,000,000 | $610,000,000 | $633,000,000 |
| Depreciation And Amortization | $578,000,000 | $580,000,000 | $610,000,000 | $633,000,000 |
| Amortization Cash Flow | $291,000,000 | $312,000,000 | $362,000,000 | $405,000,000 |
| Amortization Of Intangibles | $291,000,000 | $312,000,000 | $362,000,000 | $405,000,000 |
| Depreciation | $287,000,000 | $268,000,000 | $248,000,000 | $228,000,000 |
| Pension And Employee Benefit Expense | $-605,000,000 | $-689,000,000 | $-689,000,000 | $-9,000,000 |
| Net Income From Continuing Operations | $2,154,000,000 | $2,050,000,000 | $1,618,000,000 | $1,949,000,000 |
| Other Cash Adjustment Outside Changein Cash | - | - | - | $0 |
| Net Intangibles Purchase And Sale | - | - | - | $0 |
| Purchase Of Intangibles | - | - | - | $0 |
| Short Term Debt Payments | - | - | - | - |
| Short Term Debt Issuance | - | - | - | - |
Fetched: 2026-07-13